메뉴 건너뛰기




Volumn 2, Issue 5, 2010, Pages 171-174

Hepatocellular carcinoma in thalassemia: A critical review

Author keywords

Complication; Hemochromatosis; Hepatocellular carcinoma; Liver transplantation; Screening; Thalassemia

Indexed keywords


EID: 81255139359     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v2.i5.171     Document Type: Article
Times cited : (53)

References (35)
  • 1
    • 0347547003 scopus 로고    scopus 로고
    • The molecular pathology of the thalassemias
    • Weatherall DJ, Clegg B. editors. The thalassemia syndromes, 4th edn Oxford:Blackwell Science
    • Higgs DR, Thein SL,Woods WG. The molecular pathology of the thalassemias.In:Weatherall DJ, Clegg B, editors.The thalassemia syndromes,4th edn Oxford:Blackwell Science, 2001: 133-191
    • (2001) , pp. 133-191
    • Higgs, D.R.1    Thein, S.L.2    Woods, W.G.3
  • 5
    • 28844480321 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma
    • Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236
    • (2005) Hepatology , vol.42 , pp. 1208-1236
    • Bruix, J.1    Sherman, M.2
  • 12
    • 40849124295 scopus 로고    scopus 로고
    • Novel advancements in the management of hepatocellular carcinoma in 2008
    • Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008; 48 Suppl 1: S20-S37
    • (2008) J Hepatol , vol.48 , Issue.SUPPL. 1
    • Llovet, J.M.1    Bruix, J.2
  • 16
    • 33645068178 scopus 로고    scopus 로고
    • A prospective study of hepatocellular carcinoma incidence in thalassemia
    • Mancuso A, Sciarrino E, Renda MC, Maggio A. A prospective study of hepatocellular carcinoma incidence in thalassemia. Hemoglobin 2006; 30: 119-124
    • (2006) Hemoglobin , vol.30 , pp. 119-124
    • Mancuso, A.1    Sciarrino, E.2    Renda, M.C.3    Maggio, A.4
  • 17
    • 0346874201 scopus 로고    scopus 로고
    • Screening for hepatocellular carcinoma in cirrhosis
    • Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003; 39: 1076-1084
    • (2003) J Hepatol , vol.39 , pp. 1076-1084
    • Bolondi, L.1
  • 19
    • 7044222320 scopus 로고    scopus 로고
    • Iron, hemochromatosis, and hepatocellular carcinoma
    • Kowdley KV. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 2004; 127: S79-S86
    • (2004) Gastroenterology , vol.127
    • Kowdley, K.V.1
  • 23
    • 73149087432 scopus 로고    scopus 로고
    • Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major
    • Saffar MJ, Saffar H, Khalilian AR, Naqshvar F. Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major. East Mediterr Health J 2009; 15: 785-791
    • (2009) East Mediterr Health J , vol.15 , pp. 785-791
    • Saffar, M.J.1    Saffar, H.2    Khalilian, A.R.3    Naqshvar, F.4
  • 24
    • 24944502327 scopus 로고    scopus 로고
    • Efficacy and tolerability of peginterferon alpha- 2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection
    • Inati A, Taher A, Ghorra S, Koussa S, Taha M, Aoun E, Sharara AI. Efficacy and tolerability of peginterferon alpha- 2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection. Br J Haematol 2005; 130: 644-646
    • (2005) Br J Haematol , vol.130 , pp. 644-646
    • Inati, A.1    Taher, A.2    Ghorra, S.3    Koussa, S.4    Taha, M.5    Aoun, E.6    Sharara, A.I.7
  • 26
    • 0036106786 scopus 로고    scopus 로고
    • Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major
    • Li CK, Chan PK, Ling SC, Ha SY. Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major. Br J Haematol 2002; 117: 755-758
    • (2002) Br J Haematol , vol.117 , pp. 755-758
    • Li, C.K.1    Chan, P.K.2    Ling, S.C.3    Ha, S.Y.4
  • 28
    • 0027198484 scopus 로고
    • Recombinant alpha 2B interferon (IFN) in the treatment of chronic hepatitis C disease in thalassaemia major (TM)
    • Wonke B, Donohue SM, Hoffbrand AV, Scheuer PJ, Brown D, Dusheiko G. Recombinant alpha 2B interferon (IFN) in the treatment of chronic hepatitis C disease in thalassaemia major (TM). Bone Marrow Transplant 1993; 12 Suppl 1: 24-25
    • (1993) Bone Marrow Transplant , vol.12 , Issue.SUPPL. 1 , pp. 24-25
    • Wonke, B.1    Donohue, S.M.2    Hoffbrand, A.V.3    Scheuer, P.J.4    Brown, D.5    Dusheiko, G.6
  • 32
    • 0030771312 scopus 로고    scopus 로고
    • Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients
    • Telfer PT, Garson JA, Whitby K, Grant PR, Yardumian A, Hoffbrand AV, Wonke B. Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients. Br J Haematol 1997; 98: 850-855
    • (1997) Br J Haematol , vol.98 , pp. 850-855
    • Telfer, P.T.1    Garson, J.A.2    Whitby, K.3    Grant, P.R.4    Yardumian, A.5    Hoffbrand, A.V.6    Wonke, B.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.